Park Medi World Limited has successfully completed the acquisition of 100% stake in SVPD Healthcare Private Limited on March 20, 2026, making it a wholly owned subsidiary of the company. This development represents a significant milestone in the company's strategic expansion plan to acquire the 360-bed KP Institute of Medical Sciences (KPIMS) in Agra.

Acquisition Timeline and Progress

The acquisition forms part of Park Medi World's broader strategy to acquire KPIMS through the purchase of two target entities. The company had previously announced the completion of its acquisition of K P S Wellness Private Limited on January 30, 2026, marking the first phase of this strategic initiative.

Strategic Acquisition Details

The acquisition of SVPD Healthcare Private Limited represents the completion of one of the two target entities identified for the KPIMS acquisition strategy. Through this transaction, Park Medi World has secured 100% shareholding control, establishing SVPD Healthcare as a wholly owned subsidiary.

Regulatory Compliance and Disclosure

The company has maintained full regulatory compliance throughout the acquisition process, providing timely updates under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure follows previous announcements made on December 19, 2025, January 30, 2026, and February 26, 2026.

The completion of this acquisition brings Park Medi World closer to its objective of acquiring the entire 360-bed KP Institute of Medical Sciences facility in Agra. With both target entities now under its control, the company has positioned itself to leverage the expanded healthcare infrastructure and strengthen its presence in the medical services sector.

The transaction required no specific governmental or regulatory approvals, facilitating a smooth completion process. Park Medi World has confirmed that all relevant details have been disclosed in accordance with SEBI regulations and the information will be made available on the company's website at www.parkhospital.in .

Kotak Mahindra Mutual Fund has disclosed a substantial acquisition of shares in Park Medi World Limited, crossing the critical 5% threshold that mandates disclosure under SEBI's Substantial Acquisition of Shares and Takeovers (SAST) Regulations, 2011. The acquisition was completed on March 11, 2026, through open market transactions.

Acquisition Details

The mutual fund acquired 175,164 equity shares of Park Medi World Limited through its various investment schemes. This acquisition increased Kotak Mahindra Mutual Fund's total shareholding in the company from 21,591,213 shares to 21,766,377 shares.

Company Information

Park Medi World Limited's equity shares are listed on both BSE Limited and the National Stock Exchange of India Limited. The company has a total equity share capital of 43,19,30,864 equity shares with a face value of Rs. 2 each. This share capital structure remained unchanged following the acquisition.

Regulatory Compliance

Kotak Mahindra Mutual Fund confirmed that it does not belong to the promoter or promoter group of Park Medi World Limited. The acquisition was made purely as an investment through the fund's schemes, representing a diversification strategy in the healthcare sector.

Investment Implications

The acquisition represents Kotak Mahindra Mutual Fund's confidence in Park Medi World Limited's business prospects. The fund's investment was executed through multiple schemes, indicating a strategic allocation decision across its portfolio management framework.

The disclosure was signed by Jolly Bhatt, Compliance Officer of Kotak Mahindra Asset Management Company Limited, which serves as the investment manager for Kotak Mahindra Mutual Fund. The company maintains its corporate office in Mumbai and operates under CIN U65991MH1994PLC080009.